CMS’ survey of drug acquisition costs of pharmacies will be another controversial, complex step in transparency. Stay tuned.
posted on May 20, 2013 by
Medicaid, Medicare, Health Reform Consultant, Speaker, Author
CMS’survey of drug acquisition costs of pharmacie…
<span class="my_class">Piper</span> Report
- Medicare Episode-Based Payment Reform Demonstrations: GAO Review of Voluntary and Mandatory Models
- Use of Prescription Medicines Today and Forecasts for 2023: Valuable Market Insights from IQVIA
- Real-World Evidence in Medical Product Development: Drugs, Biologics, Diagnostics, and Devices
- Physician Practice Patterns and Perspectives on Change: Insights from National Survey
- Teen Hospital Stays for Childbirth: Latest National and State Specific Trends
- Opioid Recovery and Patient Access to Medication Assisted Treatment in Medicaid, Medicare Part D, and Private Health Insurance